tirzepatide alcohol pancreatitis risk Mounjaro and Pancreatic Cancer: Is there a link? Pancreatitis and Alcohol: Risks &

Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ

GLP-1 medications independently reduce hepatic fat and improve insulin sensitivity, so isolating lipotropic benefit requires careful interpretation

Researchers are also exploring whether these medications might reduce heart disease risk, improve kidney health, lessen fatty liver disease and even reduce cravings for alcohol

The study summary explains that, after analysing 84 people, those with what is known as starving gut respond much better to treatment (losing an average of 8.8 kilos compared to 4.5 kilos in the other group)

Over 12 weeks at 2.5 mg, you should see 12 to 24 pounds of loss if the dose is adequate

4) Petrelintide (long-acting amylin analog): Two phase 2 trials are ongoing for people with overweight or obesity, one expected to complete in March 2026